Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018677 · ClinicalTrials.gov registry record · NA
TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04018677: Completed NA study, sponsored by Stanford University.
NCT04018677 is a NA study that has completed, run by Stanford University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04018677, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. The Technical Objectives are to: 1. Establish the project team and obtain stakeholder feedback on what to include in the product. 2. Evaluate IT customization requirements and HIPAA compliance security, and privacy protocols. 3. Develop a prototype to show NCI and then a pilot version for beta and usability testing among stakeholders. 4. Enhance interoperability and test integration into health system(s) - if feasible. 5. Develop user support documentation for stakeholders.
Primary Outcome
User experiences will be assessed by measuring overall experiences.
Interventions
- BEHAVIORAL Use of TOGETHERCare app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2022-06-25 |
| Phase | NA |
What the finished NCT04018677 record still lists
NCT04018677 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Use of TOGETHERCare app is the first listed.
NCT04018677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04018677 about?
NCT04018677 is a clinical study titled "TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources". The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. ...
What is the current status of trial NCT04018677?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-05-07. Estimated completion is 2022-06-25.
What interventions are being tested in trial NCT04018677?
The interventions under investigation include: Use of TOGETHERCare app (BEHAVIORAL).
Who is sponsoring clinical trial NCT04018677?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04018677's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy